Oncology includes Verzenio, which generated $1.47 billion in Q3 2025, along with Jaypirca, Retevmo, Cyramza, and the recently approved Inluriyo for HRpositive, HER2negative breast cancer
Emerging evidence suggests that GLP-1 receptor agonists (GLP-1 RA) may offer clinical benefits in HFpEF patients through anti-inflammatory and hemodynamic effects 5,6
The insula is a pivotal brain region responsible for perceiving bodily states (such as fatigue, pain, and energy levels) and generating corresponding emotional and motivational responses
It can leave you asking, Will I be able to afford this
Cambios y Devoluciones Todas las compras realizadas tienen un plazo para su cambio
The share of covered workers enrolled in a POS plan is larger in firms with 10 to 199 workers than the share in larger firms (19% vs